Evidence map›Paper›PMID 8644855›Full record

ArticleThe American journal of pathology1996

Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.

P Thorner, J Squire, S Chilton-MacNeil, P Marrano, J Bayani, D Malkin, M Greenberg, A Lorenzana, M Zielenska

Abstract readCase Reports
In one paragraph

Article in The American journal of pathology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Is it Askin Tumour? A Question You Must Ask Even in Elderly.Journal of clinical and diagnostic research : JCDR · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Soft tissue tumors associated with EWSR1 translocation.Virchows Archiv : an international journal of pathology · 2010
    Review
  10. Perigastric extraskeletal Ewing's sarcoma: a case report.World journal of gastroenterology · 2009
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

P ThornerDepartment of Pathology, The Hospital for Sick Children, Toronto, Canada.
J Squire
S Chilton-MacNeil
P Marrano
J Bayani
D Malkin
M Greenberg
A Lorenzana
M Zielenska
Hospital for Sick Children · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of t(11;22)(q24;q12) is often considered diagnostic of Ewing sarcoma and peripheral primitive neuroectodermal tumor. We report four cases, all of which possessed this translocation as detected by reverse transcriptase polymerase chain reaction and confirmed by sequencing with or without fluorescent in situ hybridization, but none of which were Ewing sarcoma or peripheral primitive neuroectodermal tumor by histological criteria. Two were polyphenotypic tumors and two were mixed embryonal and alveolar rhabdomyosarcomas. Only one case was positive for MIC2 by immunohistochemistry and only in a rare cell. Two cases (one polyphenotypic tumor and one rhabdomyosarcoma) had double minute chromosomes with > 100 copies of the MDM2 gene. The presence of the t(11;22)(q24;ql2) translocation should probably not be considered diagnostic of Ewing sarcoma and peripheral primitive neuroectodermal tumor in the absence of supporting histological evidence. The presence of this translocation in Ewing sarcoma and peripheral primitive neuroectodermal tumor has been taken as evidence that these two tumors are related. Extending this relationship to include some polyphenotypic tumors and some rhabdomyosarcomas may not be justified unless additional evidence is gathered. Pathologists and oncologists will need to decide whether treatment regimens for tumors are better based on phenotype rather than genotype when these two profiles are seemingly in conflict.

Indexed as

Proto-Oncogene ProteinsTranscription, GeneticAbdominal NeoplasmsBiomarkers, TumorBone NeoplasmsBrain NeoplasmsChild, PreschoolDiagnosis, DifferentialDNA-Binding ProteinsFemaleGenetic MarkersHumansInfantMaleNeuroectodermal Tumors, PrimitivePolymerase Chain ReactionBiomarkers, TumorDNA-Binding ProteinsGenetic MarkersProto-Oncogene Protein c-fli-1Proto-Oncogene ProteinsTrans-Activators

Identifiers

PMID8644855
PMCPMC1861517
OpenAlexW2176099398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.